China's Foremost Bio/Pharma and Clinical Supply Chain Convention is Back

--- The ONLY conference addressing the cold chain issues faced by the pharmaceutical industry in China

BEIJING, Dec. 12, 2011 /PRNewswire-Asia/ -- Many multinational pharmaceutical companies have set up operations and manufacturing plants in China. With this in mind, however, China is still far from developing a comprehensive and efficient cold chain distribution system for pharmaceutical products. The large land mass, the extreme weather conditions across varied terrains and an inefficient transportation system across multi-tiered cities and rural areas means cold chain management is a huge challenge for the pharmaceutical industry in China.

Pharma IQ acknowledges the difficulties faced by supply chain managers looking after the Chinese market and have put together a series of expert presentations for your learning. These presentations include:

1. Overview of USFDA Office in China And GMP Trending In API Manufacturing Operations by CHARLES I. AHN,USFDA, ASSISTANT COUNTRY DIRECTOR, CHINA SHANGHAI OFFICE
2. Current trends and weaknesses in China's pharmaceutical cold chain distribution by Zhang Linghui, Assistant Secretary General, China Pharmaceutical Technology Exchange
3. Cold chain management of finished products effectively minimising losses due to temperature excursions by Marco A.Vega, China Quality Leader, Lilly China

Please email enquiry@iqpc.com.sg to receive a copy of the presentations.

In addition, Pharma IQ will be holding the 2nd Annual Bio/Pharmaceutical Cold Chain Management China (http://bit.ly/tfOwuG) taking place on the 28-29 February 2012 in Beijing which will be looking at how pharmaceutical and biotechnology companies can manage the clinical trial supply chain more effectively in China. This is part of the CHINA BIO/PHARMA AND CLINICAL SUPPLY CHAIN CONVENTION 2012 (http://bit.ly/vcu85u) which is set to become the largest gathering of senior level pharmaceutical supply chain professionals in China. Over 200 Heads and Directors of supply chain, logistics, procurement, clinical trial supply, clinical operation, and clinical research are expected to gather to determine how they can drive supply chain performance within their organisations.

Key speakers at this event include the following:

• Yong Guo, Head of Supply Chain, Novartis China
• Liu Weizhan, Secretary General, Cold Chain Association, China Federation of Logistics and Purchasing
• Gu Weijun, Secretary General, China Pharmaceutical Association of Plant Engineering
• Alex Xu, Head of Suppy Chain, Lilly China
• Xu Jin, Vice President of Supply Chain, Tasly Group

PLUS! Pharma IQ has 30 VIP passes available for qualified pharmaceutical/biotechnology companies for this event. Please email yip.teckchee@iqpc.com.sg to find out if you qualify for the pass.

Log on to http://bit.ly/uZsnWt for the complete convention agenda and list of topics that will be covered at the 2nd Annual Bio/Pharmaceutical Cold Chain China.

To register for the 2nd Annual Bio/Pharmaceutical Cold Chain China, send an email to enquiry@iqpc.com.sg

About IQPC Worldwide:

For over thirty years, IQPC has helped the world's leading corporations solve their business challenges through the sharing of practical industry solutions and global best practice. In the process, the company has built a formidable reputation for quality and value. The world's most progressive companies have benefited from IQPC's unrivalled global reach, which has connected international expertise with regional and local leaders.

For more information, please contact:

Joyce Shi
Marketing Manager
Tel: +65-6722-9446
Email: Joyce.shi@iqpc.com.sg